1-2 of 2
Paul Tamburini, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First in Human Single-Ascending Dose Study: Safety, Biomarker, Pharmacokinetics and Exposure-Response Relationships of ALXN1210, a Humanized Monoclonal Antibody to C5, with Marked Half-Life Extension and Potential for Significantly Longer Dosing Intervals

Leonardo Sahelijo, MD, Arshad Mujeebuddin, MD, David Mitchell, PhD, Richard Larouche, MD, Zhao-Xue Yu, PhD, Yuchun Zhang, MD, Rekha Patel, Melissa Lasaro, PhD, Keith Bouchard, Bruce Andrien, PhD, Yi Wang, MD, Paul Tamburini, PhD, Susan Macdonald, PhD, Douglas Sheridan, PhD, Paresh Soni, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4777.
https://doi.org/10.1182/blood.V126.23.4777.4777
Published: 2015
Journal Articles

A Rare Genetic Polymorphism In C5 Confers Poor Response To The Anti-C5 Monoclonal Antibody Eculizumab In 11 Japanese Patients With PNH

Jun-ichi Nishimura, MD, PhD, Masaki Yamamoto, MD, Shin Hayashi, MD, PhD, Kazuma Ohyashiki, MD, PhD, Kiyoshi Ando, MD, PhD, Hideyoshi Noji, MD, PhD, Kunio Kitamura, MD, PhD, Tetsuya Eto, MD, PhD, Toru Takahashi, MD, Masayoshi Masuko, MD, PhD, Takuro Matsumoto, MD, Yuji Wano, MD, PhD, Tsutomu Shichishima, MD, PhD, Hirohiko Shibayama, Masakazu Hase, PhD, Li Lan, MD, Krista Johnson, Paul Tamburini, PhD, Johji Inazawa, MD, PhD, Taroh Kinoshita, PhD, Yuzuru Kanakura
Journal: Blood
Blood (2013) 122 (21): 3709.
https://doi.org/10.1182/blood.V122.21.3709.3709
Published: 2013